Papakitsou Ioanna, Papazachariou Andria, Filippatos Theodosios D, Ioannou Petros
Department of Internal Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.
School of Medicine, University of Crete, 71003 Heraklion, Greece.
Hematol Rep. 2024 Dec 13;16(4):804-814. doi: 10.3390/hematolrep16040076.
Thrombocytopenia, defined as a platelet count of less than 150 × 10/L, is a frequent condition among hospitalized patients and presents unique challenges in diagnosis and management. Despite its commonality, data on incidence and related risk factors in medical inpatients remain limited, especially in older people.
A 2-year prospective cohort study with a 3-year follow-up was conducted on inpatients aged ≥65 years admitted to a medical ward. Clinical data were collected, including demographics, comorbidities, laboratory results, and outcomes. Multivariate logistic regression analysis assessed risk factors associated with non-resolution of thrombocytopenia and mortality.
The study included 961 older inpatients with a mean age of 82 years. Thrombocytopenia occurred in 22.6% of the study population. The most common causes were infections (57.4%) and drug-induced thrombocytopenia (25.3%). The non-resolution of thrombocytopenia was noted in 59% of patients. In-hospital and 3-year mortality was significantly higher in this subgroup compared to the rest (24.5% vs. 12.7%, = 0.015) and (72.4% vs. 59.8%, = 0.04, respectively). In multivariate analysis, nadir platelet count and hematologic disease were independent factors associated with the non-resolution of thrombocytopenia. Furthermore, in individuals with thrombocytopenia, the administration of norepinephrine ( < 0.001) and a higher clinical frailty score ( < 0.001) were observed as independent mortality predictors.
Thrombocytopenia in older medical inpatients is associated with poor prognosis, particularly in those with non-resolution thrombocytopenia. Early identification and targeted management may improve outcomes.
血小板减少症定义为血小板计数低于150×10⁹/L,是住院患者中的常见病症,在诊断和管理方面存在独特挑战。尽管其很常见,但关于内科住院患者的发病率及相关危险因素的数据仍然有限,尤其是在老年人中。
对入住内科病房的≥65岁住院患者进行了一项为期2年的前瞻性队列研究,并进行了3年随访。收集了临床数据,包括人口统计学、合并症、实验室检查结果和结局。多因素逻辑回归分析评估了与血小板减少症未缓解及死亡率相关的危险因素。
该研究纳入了961名老年住院患者,平均年龄82岁。研究人群中22.6%发生了血小板减少症。最常见的原因是感染(57.4%)和药物性血小板减少症(25.3%)。59%的患者血小板减少症未缓解。与其余患者相比,该亚组的住院死亡率和3年死亡率显著更高(分别为24.5%对12.7%,P = 0.015)和(72.4%对59.8%,P = 0.04)。在多因素分析中,最低血小板计数和血液系统疾病是与血小板减少症未缓解相关的独立因素。此外,在血小板减少症患者中,观察到去甲肾上腺素的使用(P < 0.001)和较高的临床衰弱评分(P < 0.001)是独立的死亡预测因素。
老年内科住院患者的血小板减少症与不良预后相关,尤其是那些血小板减少症未缓解的患者。早期识别和针对性管理可能改善结局。